| Drug Name: | Gemtuzumab ozogamicin (220578-59-6) |
|---|---|
| PubChem ID: | 124030962 |
| SMILES: | C1[C@H]([C@H]([C@@H](C[C@@]1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC4=C(C=C3)OC5(C(=O)C6=C(C=C(C=C6OC5(O4)C7=CC(=C(C=C7)O)O)O)O)O)O |
| InchiKey: | MOSSDJVWNKZTPZ-KVEKGOQTSA-N |
| Therapeutic Category: | Antineoplastic Agents, Immunotoxins, Noxae |
| Molecular Weight (dalton) | : | 816.677 |
| LogP | : | 2.0289 |
| Ring Count | : | 4 |
| Hydrogen Bond Acceptor Count | : | 18 |
| Hydrogen Bond Donor Count | : | 10 |
| Total Polar Surface Area | : | 316.73 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category